Cancer
Modified drug gives a ‘green light’ for its own success
29 Jul 2014A modified anticancer drug can simultaneously target tumor sites and show whether or not it is working
Finding consensus on target genes
3 Jun 2014A panel of p53 variants helps scientists confidently identify genes controlled by the master regulator protein
Stapling together cancer therapy
6 May 2014Computer simulations help design molecules with potential as a cancer therapy
The significance of silence
22 Apr 2014An enzyme that silences DNA activity may be crucially involved in health and cancer
One protein, two important roles
28 Jan 2014A molecular mechanism that directs both cell growth and death via one protein could underpin more efficient cancer therapies
Lymphoma-linked risk factor identified
24 Sep 2013A specific genetic variant expressed in a key immune protein heightens an individual’s chance of developing follicular lymphoma
A biomarker for myeloma
2 Jul 2013A protein called FAIM could help doctors to parse which cancer patients will respond to multiple myeloma therapy
Leukemia ‘blasted’ through new drug target
2 Jul 2013By inhibiting an enzyme called MNK, researchers have found a way to halt the growth of blast crisis phase CML
Sensitive software detects diversity
23 Apr 2013A new computer program readily identifies rare mutations harbored within diverse populations of cancer cells and microorganisms
Characterizing a cancer complex
11 Sep 2012Revelation of the function of a protein complex that controls cell proliferation in fruit fly wings provides insights into tumor growth
Fighting cancer cells by stealth
11 Sep 2012Through a combination of two powerful methodologies, researchers at the A*STAR Institute of Bioengineering and Nanotechnology drive forward promising developments for gene therapy
Bringing brighter light into living bodies
17 Jul 2012Fluorescent dyes with aggregation-induced emission provide new probes for cancer diagnosis and therapy